Getinge Interim Report January-June 2016

Second quarter of 2016 in brief  

  •  Order intake: -0.7% to SEK 7,460 M (7,516). The order intake grew organically by 3.0%.
  •  Net sales: -3.5% to SEK 6,927 M (7,181). Net sales fell organically by 0.3%.
  •  Gross margin: 45.7% (46.4). Affected negatively by currencies.
  •  EBITA*: +10.2% to SEK 788 M (715).
  •  Restructuring and integration costs: SEK 133 M (86).
  •  Profit before tax: +28.0% to SEK 311 M (243).
  •  Earnings per share: SEK 0.93 (0.71).
  •  Good cost control: Administrative and selling expenses declined by 8.4%.
  •  New President of Acute Care Therapies: Jens Viebke
  •  FDA update: Getinge is still awaiting a decision by the FDA regarding the remediation plan in Hechingen.
  •  Strengthened customer offering: Launches include a new mobile operating table.
January-June 2016 in brief 
  •  Order intake: -2.2% to SEK 14,384 M (14,708). The order intake grew organically by 0.5%.
  •  Net sales: -4.2% to SEK 13,304 M (13,893). Net sales fell organically by 1.7%.
  •  Gross margin: 46.4% (46.6).
  •  EBITA*: -1.7% to SEK 1,408 M (1,432).
  •  Restructuring and integration costs: SEK 260 M (270).
  •  Profit before tax: +20.6% to SEK 468 M (388).
  •  Earnings per share: SEK 1.39 (1.09).
  •  The transformation and efficiency-enhancement program was initiated and a Group-wide sales organization was established.
Financial summary  
MSEK Q2 2016 Q2 2015 Change % Jan-Jun 2016 Jan-Jun 2015 Change % Rolling 12M FY 2015
Order intake 7 460  7 516 -0.7% 14 384 14 708 -2.2% 30 107 30 431
Net sales 6 927  7 181 -3.5% 13 304 13 893 -4.2% 29 646 30 235
Gross Profit 3 167  3 331 -4.9% 6 178 6 473 -4.6% 13 868 14 163
Gross margin 45.7%  46.4% -0.7% 46.4% 46.6% -0.2% 46.8% 46.8%
EBITA* 788  715 10.2%  1 408  1 432 -1.7%  4 155  4 179
EBITA margin* 11.4%  10.0% 1.4%  10.6%  10.3% 0.3%  14.0%  13.8%
Operating profit 473  428 10.5% 789 762 3.5% 2 756 2 729
Profit before tax 311  243 28.0% 468 388 20.6% 2 077 1 997
Net profit 227  177 28.2% 342 283 20.8% 1 516 1 457
Earnings per share 0.93       0.71     31.0%          1.39   1.09   27.5%                6.13   5.83
Cash flow from operations 463                 598 -22.6% 1 163                               1 252 -7.1%              3 369 3 458

* before restructuring, acquisition and integration cost
                       

 

Getinge Group is a leading global provider of innovative solutions for operating rooms, intensive-care units, hospital wards, sterilization departments, elderly care and for life science companies and institutions. With a genuine passion for life we build quality and safety into every system. Our unique value proposition mirrors the continuum of care, enhancing efficiency throughout the clinical pathway. Based on our first-hand experience and close partnerships, we are able to exceed expectations from customers – improving the every-day life for people, today and tomorrow. 

The information is such that Getinge AB must disclose in accordance with the Swedish Securities Market Act and/or the Financial Instruments Trading Act. 

Tags:

About Us

Getinge is a global provider of innovative solutions for operating rooms, intensive-care units, sterilization departments and for life science companies and institutions. Based on our first-hand experience and close partnerships with clinical experts, healthcare professionals and medtech specialists, we are improving the every-day life for people, today and tomorrow.

Subscribe